BioCardia
BCDA
8 hedge funds and large institutions have $2.62M invested in BioCardia in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0.03% less ownership
Funds ownership: 0.63% → 0.6% (-0.03%)
8% less capital invested
Capital invested by funds: $2.85M → $2.62M (-$229K)
33% less funds holding
Funds holding: 12 → 8 (-4)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$6.52K |
| 2 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$474 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$58K |
| 2 |
Millennium Management
New York
|
-$41K |
| 3 |
Jane Street
New York
|
-$35K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$364 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $1.58M | +$474 | +13 | +0% |
|
|
RAM
2
Roumell Asset Management
Chevy Chase,
Maryland
| $756K | – | – | – |
|
|
3
Osaic Holdings
Scottsdale,
Arizona
| $199K | +$6.52K | +179 | +3% |
|
4
Brown Advisory
Baltimore,
Maryland
| $75K | – | – | – |
|
|
5
Bank of America
Charlotte,
North Carolina
| $13K | -$364 | -10 | -3% |
|
6
Morgan Stanley
New York
| $1K | – | – | – |
|
|
CH
7
CVI Holdings
Wilmington,
Delaware
| – | -$58K | -1,627 | Closed |
|
|
8
Millennium Management
New York
| – | -$41K | -1,151 | Closed |
|
|
9
Jane Street
New York
| – | -$35K | -979 | Closed |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| – | -$6K | -173 | Closed |
|
BCDA Hedge Fund Activity: Q3 2020 in Review
8 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in BioCardia (BCDA) for Q3 2020, worth a combined $2.62M — down 8% from $2.85M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BCDA and 0 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Osaic Holdings, adding an estimated $6.52K. The largest seller was CVI Holdings, exiting entirely with an estimated $58K sold.
- 8 institutional investors held BioCardia (BCDA) as of Q3 2020, down from 12 in Q2 2020.
- Funds reported $2.62M of BioCardia stock for Q3 2020, down 8% quarter-over-quarter.
- 0 funds opened new BioCardia positions in Q3 2020 and 4 closed out, a net change of -4 holders.
- The largest BioCardia buyer in Q3 2020 was Osaic Holdings, an estimated $6.52K added.
- The largest BioCardia seller in Q3 2020 was CVI Holdings, an estimated $58K sold.
Based on aggregated 13F filings for Q3 2020.